SkyMedAI Information

𝐇𝐞𝐚𝐥𝐭𝐡 𝐀𝐈 𝐀𝐝𝐯𝐢𝐬𝐨𝐫𝐲 focused on strategy, validation, commercialization, and guardrails for pharma, medtech, and consumer health products. 𝐓𝐡𝐞 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞: Led by Dr. Amir Lahav, former Harvard Medical School professor and digital health leader at Pfizer, with broad experience across healthcare, life sciences, and consumer health — supported by a network of clinicians, scientists, investors, and entrepreneurs. 𝐓𝐡𝐞 𝐖𝐨𝐫𝐤: Turning visionary ideas into commercial success, from early strategy through market adoption and scale. Specialty areas include clinical validation, AI guardrails, and investment diligence for medical-grade and consumer health solutions 𝐓𝐚𝐫𝐠𝐞𝐭 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐬: Investors · Health Systems · Regulators & Payers · Pharma & Life Sciences · Patient Advocacy Groups · Startups & Emerging Tech · Medtech, Healthtech & BigTech 𝐂𝐨𝐫𝐞 𝐀𝐝𝐯𝐢𝐬𝐨𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞: Clinical & Scientific Validation · Medical Devices & Patient Apps · Wearables & Digital Endpoints · AI Safety for Medical & Consumer · Pharma Commercial & Clinical Trials · Investment Strategy & Due Diligence · Product Development & GTM Strategy 𝐓𝐡𝐞 𝐀𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞: Scientific depth · Clinical expertise · Honesty over diplomacy · Creative problem-solving · Connections that open doors · Agility to see what others miss · Priority speaking at the DHAI Summit 👉 𝐋𝐞𝐭'𝐬 𝐭𝐚𝐥𝐤: https://skymedai.com/